Indaptus Therapeutics Director Tim Ruan Resigns

What Happened
Indaptus Therapeutics, Inc. (INDP) filed an 8-K on September 4, 2026 reporting that director Tim Ruan notified the Board of his resignation on September 2, 2026, effective immediately. The company stated Mr. Ruan’s resignation was not due to any disagreement with the company on operations, policies or practices. The report was made under Item 5.02 (Departure of Directors or Certain Officers).

Key Details

• Tim Ruan resigned from the Board of Directors on September 2, 2026; resignation effective immediately.
• Company disclosed the resignation was not the result of any disagreement with the company’s operations, policies or practices.
• The 8-K was filed September 4, 2026 and included standard exhibit filing (Inline XBRL cover page, Exhibit 104).

Why It Matters
A board member’s departure is a governance event investors should note: it changes board composition and could affect committee membership or oversight until a replacement is named. The company provided no disagreement-related reason and did not disclose any financial impact. Investors should watch future SEC filings and company statements for any announcement of a new director or changes to board committees.